- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Therapeutic Targets for Migraine
Authors
Keywords
-
Journal
Biomedicines
Volume 11, Issue 2, Pages 569
Publisher
MDPI AG
Online
2023-02-15
DOI
10.3390/biomedicines11020569
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The PACAP pathway is independent of CGRP in mouse models of migraine: possible new drug target?
- (2022) Charlotte Ernstsen et al. BRAIN
- Involvement of adenosine signaling pathway in migraine pathophysiology: A systematic review of clinical studies
- (2022) Janu Thuraiaiyah et al. CEPHALALGIA
- Effect of KATP channel blocker glibenclamide on PACAP38-induced headache and hemodynamic
- (2022) Lili Kokoti et al. CEPHALALGIA
- Involvement of adenosine signaling pathway in migraine pathophysiology: a systematic review of preclinical studies
- (2022) Janu Thuraiaiyah et al. JOURNAL OF HEADACHE AND PAIN
- The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates
- (2022) Lars Jacob Stovner et al. JOURNAL OF HEADACHE AND PAIN
- European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
- (2022) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Selective activation of Gαob by an adenosine A1 receptor agonist elicits analgesia without cardiorespiratory depression
- (2022) Mark J. Wall et al. Nature Communications
- A c-Fos activation map in nitroglycerin/levcromakalim-induced models of migraine
- (2022) Shouyi Wu et al. JOURNAL OF HEADACHE AND PAIN
- PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine
- (2022) Song Guo et al. JOURNAL OF HEADACHE AND PAIN
- Novel Fluorescently Labeled PACAP and VIP Highlight Differences between Peptide Internalization and Receptor Pharmacology
- (2022) Tyla I. Alexander et al. ACS Pharmacology & Translational Science
- Opening of ATP sensitive potassium channels causes migraine attacks with aura
- (2021) Mohammad Al-Mahdi Al-Karagholi et al. BRAIN
- PACAP induces light aversion in mice by an inheritable mechanism independent of CGRP
- (2021) Adisa Kuburas et al. JOURNAL OF NEUROSCIENCE
- The role of peripheral adenosine receptors in glutamate-induced pain nociceptive behavior
- (2021) S. J. Macedo-Júnior et al. Purinergic Signalling
- The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice
- (2021) Jessica Ailani et al. HEADACHE
- The Medicinal Chemistry of Caffeine
- (2021) Giuseppe Faudone et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Effect of KATP Channel Blocker Glibenclamide on CGRP-Induced Headache and Hemodynamic in Healthy Volunteers
- (2021) Hande Coskun et al. Frontiers in Physiology
- Smooth muscle ATP-sensitive potassium channels mediate migraine-relevant hypersensitivity in mouse models
- (2021) Sarah L Christensen et al. CEPHALALGIA
- The role of TRP ion channels in migraine and headache
- (2021) Luigi Francesco Iannone et al. NEUROSCIENCE LETTERS
- PAC1 receptor blockade reduces central nociceptive activity
- (2020) Jan Hoffmann et al. PAIN
- ATP sensitive potassium (KATP) channel inhibition: A promising new drug target for migraine
- (2020) Sarah L Christensen et al. CEPHALALGIA
- Benefit and Risk Evaluation of Biased μ-Receptor Agonist Oliceridine versus Morphine
- (2020) Albert Dahan et al. ANESTHESIOLOGY
- A Phase I, Randomized, Single‑Blind, Placebo‑Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Oral TRV250, a G Protein-Selective Delta Receptor Agonist, in Healthy Subjects
- (2020) Michael J. Fossler et al. CNS DRUGS
- Cerebrovascular effects of glibenclamide investigated using high-resolution magnetic resonance imaging in healthy volunteers
- (2020) Mohammad Al-Mahdi Al-Karagholi et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Serum CGRP, VIP, and PACAP usefulness in migraine: a case–control study in chronic migraine patients in real clinical practice
- (2020) Sara Pérez-Pereda et al. MOLECULAR BIOLOGY REPORTS
- A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention
- (2020) Messoud Ashina et al. CEPHALALGIA
- A non‐convulsant delta‐opioid receptor agonist, KNT‐127, reduces cortical spreading depression and nitroglycerin‐induced allodynia
- (2020) Zachariah Bertels et al. HEADACHE
- Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase Activating Peptide
- (2019) Cristina Moldovan Loomis et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The American Headache Society’s Position Statement on Integrating New Migraine Treatments into Clinical Practice – Comments
- (2019) James A. Charles et al. HEADACHE
- Opening of ATP-sensitive potassium channels causes migraine attacks: a new target for the treatment of migraine
- (2019) Mohammad Al-Mahdi Al-Karagholi et al. BRAIN
- PACAP27 induces migraine-like attacks in migraine patients
- (2019) Hashmat Ghanizada et al. CEPHALALGIA
- Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial
- (2019) Hans-Christoph Diener et al. CEPHALALGIA
- Levcromakalim, an Adenosine Triphosphate‐Sensitive Potassium Channel Opener, Dilates Extracerebral but not Cerebral Arteries
- (2019) Mohammad Al‐Mahdi Al‐Karagholi et al. HEADACHE
- Migraine and the trigeminovascular system—40 years and counting
- (2019) Messoud Ashina et al. LANCET NEUROLOGY
- Pituitary Adenylate Cyclase-Activating Polypeptide: 30 Years in Research Spotlight and 600 Million Years in Service
- (2019) Viktoria Denes et al. Journal of Clinical Medicine
- Reduced TRPM8 expression underpins reduced migraine risk and attenuated cold pain sensation in humans
- (2019) Narender R. Gavva et al. Scientific Reports
- Characterization of the trigeminovascular actions of several adenosine A2A receptor antagonists in an in vivo rat model of migraine
- (2018) Kristian A. Haanes et al. JOURNAL OF HEADACHE AND PAIN
- CGRP as the target of new migraine therapies — successful translation from bench to clinic
- (2018) Lars Edvinsson et al. Nature Reviews Neurology
- Effects of systemic inhibitors of acid-sensing ion channels 1 (ASIC1) against acute and chronic mechanical allodynia in a rodent model of migraine
- (2018) Clément Verkest et al. BRITISH JOURNAL OF PHARMACOLOGY
- Delta opioid receptor agonists are effective for multiple types of headache disorders
- (2018) Laura S. Moye et al. NEUROPHARMACOLOGY
- Tonic regulation of middle meningeal artery diameter by ATP-sensitive potassium channels
- (2017) Arsalan U Syed et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
- (2016) Zsolt Hepp et al. CEPHALALGIA
- Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors’ responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?
- (2016) XiChun Zhang et al. CEPHALALGIA
- Anatomy and immunochemical characterization of the non-arterial peptidergic diffuse dural innervation of the rat and Rhesus monkey: Implications for functional regulation and treatment in migraine
- (2016) Frank L Rice et al. CEPHALALGIA
- Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine
- (2016) Song Guo et al. PAIN
- A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression
- (2016) Erica M. Richards et al. PSYCHOPHARMACOLOGY
- Meningeal transient receptor potential channel M8 activation causes cutaneous facial and hindpaw allodynia in a preclinical rodent model of headache
- (2015) Carolina C Burgos-Vega et al. CEPHALALGIA
- Two TRPV1 receptor antagonists are effective in two different experimental models of migraine
- (2015) Jannis E Meents et al. JOURNAL OF HEADACHE AND PAIN
- δ-Opioid receptor agonists inhibit migraine-related hyperalgesia, aversive state and cortical spreading depression in mice
- (2014) Amynah A Pradhan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Dipyridamole-induced headache and lower recurrence risk in secondary prevention of ischaemic stroke: apost hocanalysis
- (2014) G. Davidai et al. EUROPEAN JOURNAL OF NEUROLOGY
- Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Dilates Cerebellar Arteries Through Activation of Large-Conductance Ca2+-Activated (BK) and ATP-Sensitive (KATP) K+ Channels
- (2014) Masayo Koide et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Enhanced Behavioral Responses to Cold Stimuli following CGRPα Sensory Neuron Ablation are Dependent on TRPM8
- (2014) Eric S McCoy et al. Molecular Pain
- Expression and Characterization of Purinergic Receptors in Rat Middle Meningeal Artery–Potential Role in Migraine
- (2014) Kristian Agmund Haanes et al. PLoS One
- Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients
- (2013) Bernadett Tuka et al. CEPHALALGIA
- pH-Evoked Dural Afferent Signaling Is Mediated by ASIC3 and Is Sensitized by Mast Cell Mediators
- (2013) Jin Yan et al. HEADACHE
- Genome-wide meta-analysis identifies new susceptibility loci for migraine
- (2013) Verneri Anttila et al. NATURE GENETICS
- Acid-sensing ion channel 1: A novel therapeutic target for migraine with aura
- (2012) Philip R. Holland et al. ANNALS OF NEUROLOGY
- Two Mechanisms Involved in Trigeminal CGRP Release: Implications for Migraine Treatment
- (2012) Paul L. Durham et al. HEADACHE
- Black mamba venom peptides target acid-sensing ion channels to abolish pain
- (2012) Sylvie Diochot et al. NATURE
- Adenosine and its receptors as therapeutic targets: An overview
- (2012) Sakshi Sachdeva et al. SAUDI PHARMACEUTICAL JOURNAL
- The ‘headache tree’ via umbellulone and TRPA1 activates the trigeminovascular system
- (2011) Romina Nassini et al. BRAIN
- Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers
- (2011) Faisal Mohammad Amin et al. CEPHALALGIA
- Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice
- (2011) Adrienn Markovics et al. NEUROBIOLOGY OF DISEASE
- TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Δ9-tetrahydrocannabiorcol
- (2011) David A Andersson et al. Nature Communications
- The transient receptor potential family of ion channels
- (2011) Bernd Nilius et al. GENOME BIOLOGY
- TRPV1 receptor blockade is ineffective in different in vivo models of migraine
- (2010) Oliver Summ et al. CEPHALALGIA
- Presence and vascular pharmacology of KATP channel subtypes in rat central and peripheral tissues
- (2010) Kenneth Beri Ploug et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- KATP channel blockade protects midbrain dopamine neurons by repressing a glia-to-neuron signaling cascade that ultimately disrupts mitochondrial calcium homeostasis
- (2010) Damien Toulorge et al. JOURNAL OF NEUROCHEMISTRY
- A Gain-of-Function Mutation in TRPA1 Causes Familial Episodic Pain Syndrome
- (2010) Barbara Kremeyer et al. NEURON
- Localization of large conductance calcium-activated potassium channels and their effect on calcitonin gene-related peptide release in the rat trigemino–neuronal pathway
- (2010) H. Wulf-Johansson et al. NEUROSCIENCE
- Impact of Recent Prior Opioid Use on Rizatriptan Efficacy. A Post Hoc Pooled Analysis
- (2009) Tony W. Ho et al. HEADACHE
- The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission
- (2009) G. A. Lambert et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- KATP channels in pig and human intracranial arteries
- (2008) Kenneth Beri Ploug et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice
- (2008) Katalin Sándor et al. PAIN
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now